peptide fragment is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2026-08-01. Where a claim depends on a specific study, the study is described rather than over-claimed.
Regulatory status differs by country, but TB-500 is not an approved pharmaceutical in major jurisdictions. It is commonly sold as a research chemical for laboratory use, which places responsibility for identity and purity on the supplier and the laboratory. Published human data are limited, and most reports involve preclinical models or cell culture. Questions about whether the fragment mimics all actions of thymosin beta-4, and under which conditions, remain open. Independent verification of any material is therefore a practical requirement in research settings.
TB-500 is a synthetic heptapeptide with the sequence Ac-LKKTETQ. It corresponds to a short N-terminal region of thymosin beta-4, a 43-amino-acid protein found in many cell types. The fragment contains an actin-binding motif, which is one reason it appears in laboratory studies of cell migration and cytoskeletal dynamics. TB-500 is not the full-length protein and is produced as a research chemical rather than an approved therapeutic agent. Its molecular weight is approximately 889 Da.
Dry powder is commonly held at minus twenty degrees Celsius, with some suppliers recommending lower temperatures for long-term archival storage. Once dissolved, solutions are typically kept cold and protected from light, since aqueous peptide solutions can lose integrity through hydrolysis or oxidation over time. Stability data specific to this fragment are limited in the public literature, and much of the guidance comes from general peptide handling practice rather than from controlled degradation studies. Users therefore treat stated shelf lives as approximate rather than fixed.
Identity and purity are normally assessed with reversed-phase high-performance liquid chromatography, paired with mass spectrometry to confirm molecular mass. A certificate of analysis reports a purity percentage, usually derived from chromatographic peak area, but that figure does not by itself prove a correct sequence or the absence of counterions. Independent verification may include amino acid analysis or peptide mapping. Batch-to-batch variation is a documented concern in the research chemical market, and the gap between a quoted purity value and actual peptide content can be substantial when the material is a salt or retains residual water.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C38H68N10O14 | Calculated for the acetylated heptapeptide |
| Molecular weight | ~889 Da | Monoisotopic mass approximately 889.0 Da |
| Amino acid sequence | Ac-LKKTETQ | N-terminal acetylated seven-residue peptide |
| Appearance | White to off-white powder | Typically supplied as a lyophilized solid |
| Solubility class | Water-soluble | Peptides of this size generally dissolve in aqueous media |
Interest in the compound comes largely from studies of the parent protein, which participates in actin sequestration, cell migration and tissue repair processes. Whether a short fragment reproduces those activities is a separate question that remains open in the published record. Many summaries describe mechanisms by analogy to thymosin beta-4 rather than from direct measurements on the fragment. Claims about activity should be treated as provisional unless a cited study specifies the exact peptide, its purity and the assay used.
TB-500 is a laboratory label applied to a short synthetic peptide that is widely described as a fragment of thymosin beta-4, an actin-binding protein present in most mammalian cells. Suppliers and review articles usually present TB-500 as the N-terminal region of that protein, but the exact sequence attached to the name is not consistent across sources. Some product descriptions list a seven-residue chain; others use the label loosely for the parent protein itself. Because of that variation, any technical discussion of TB-500 needs to state which sequence is meant.
The seven-residue chain carries several polar and charged side chains, so it dissolves readily in water and in aqueous buffers near neutral pH. No cysteine is present, so disulphide formation is not a concern and reducing agents are unnecessary. Dilute ammonium hydroxide or acetonitrile-water mixtures are sometimes used for stock solutions when initial dissolution is slow. Strongly alkaline conditions and prolonged contact with oxidising agents are avoided because they can modify lysine-containing stretches, and haze in solution usually signals incomplete dissolution or aggregated material.
Identity and purity are checked with reversed-phase high-performance liquid chromatography, which separates the target sequence from truncated or deletion analogues, and with mass spectrometry, which confirms the expected molecular mass. Amino acid analysis and peptide mapping give orthogonal confirmation but are used less often outside specialist laboratories. Counter-ion content varies: material purified on trifluoroacetic acid gradients retains trifluoroacetate, and ion exchange can convert the salt form. Residual water and solvent are measured by Karl Fischer titration or thermogravimetric analysis, and any purity figure should be read together with the method used to obtain it.
The regulatory position is broadly consistent across major jurisdictions: no thymosin beta-4 fragment is an approved medicine, and laboratory material is commonly labelled as not intended for human consumption. Anti-doping rules in sport list thymosin beta-4 and its fragments among prohibited peptide hormones. Because these products travel through research-chemical channels rather than pharmaceutical supply chains, quality varies considerably between vendors. Independent testing of identity, purity and sterility is the only dependable check, and a certificate of analysis describes one batch rather than a supplier's whole catalogue.
Lyophilized peptide powder is normally held desiccated at −20 °C, with −80 °C used for longer storage periods. Allowing a sealed vial to reach room temperature before opening is standard practice, because condensation forming on cold powder introduces moisture. Once dissolved, solutions are typically kept cold and shielded from light. Repeated freeze-thaw cycles are avoided because they encourage aggregation and gradual loss of material. These conventions are general to synthetic peptides rather than unique to any one sequence.
Thymosin beta-4 is a 43-residue actin-binding protein found in most mammalian cell types, where it participates in cytoskeletal regulation and cell migration. TB-500 represents only a short fragment of that protein and does not include the remaining residues. Whether the isolated fragment reproduces the full range of activities reported for the intact protein remains an open question. Researchers commonly treat the two as related but distinct entities when comparing results.
Published work involving this sequence spans actin-binding assays, cell-migration studies, wound-healing models, and cardiovascular or musculoskeletal experiments. Much of the biological rationale derives from in vitro systems and animal models, and the number of controlled human studies is small. Reported outcomes vary across preparations, doses, and routes, which complicates comparison between studies. Reviews generally describe the evidence base as preliminary rather than settled. Mechanistic explanations are often proposed by analogy to the parent protein rather than demonstrated directly.
Drug content Release of medicament from base Medicament penetration Consistency of the preparation Absorption of medicament into blood stream Irritant effect Properties which affect choice of an ointment base are:
Therapeutic touch (TT), or non-contact therapeutic touch (NCTT), also generically called healing touch, is a pseudoscientific energy therapy which practitioners claim promotes healing and reduces pain and anxiety. "Therapeutic Touch" is a registered trademark in Canada for the "[s]tructured and standardized healing practice performed by practitioners trained to be sensitive to the receiver's energy field that surrounds the body;...no touching is required." Practitioners of therapeutic touch state that by placing their hands on, or near, a patient, they are able to detect and manipulate what they say is the patient's energy field. One highly cited study, designed by the then-nine-year-old Emily Rosa and published in the Journal of the American Medical Association in 1998, found that practitioners of therapeutic touch could not detect the presence or absence of a hand placed a few inches above theirs when their vision was obstructed. Simon Singh and Edzard Ernst concluded in their 2008 book Trick or Treatment that "the energy field was probably nothing more than a figment in the imaginations of the healers". The American Cancer Society noted, "Available scientific evidence does not support any claims that TT can cure cancer or other diseases." A 2004 Cochrane review found no good evidence that it helped with wound healing, but the authors withdrew it in 2016 out of "serious concerns over the validity of included studies".
Size-exclusion chromatography (also called gel permeation chromatography), sometimes coupled with static light scattering, can used to determine the number-average molecular weight, weight-average molecular weight, and dispersity. Scattering techniques, such as static light scattering and small-angle neutron scattering, are used to determine the dimensions (radius of gyration) of macromolecules in solution or in the melt. These techniques are also used to characterize the three-dimensional structure of microphase-separated block polymers, polymeric micelles, and other materials. Wide-angle X-ray scattering (also called wide-angle X-ray diffraction) is used to determine the crystalline structure of polymers (or lack thereof). Spectroscopy techniques, including Fourier-transform infrared spectroscopy, Raman spectroscopy, and nuclear magnetic resonance spectroscopy, can be used to determine the chemical composition. Differential scanning calorimetry is used to characterize the thermal properties of polymers, such as the glass-transition temperature, crystallization temperature, and melting temperature. The glass-transition temperature can also be determined by dynamic mechanical analysis. Thermogravimetry is a useful technique to evaluate the thermal stability of the polymer. Rheology is used to characterize the flow and deformation behavior. It can be used to determine the viscosity, modulus, and other rheological properties.
A year later, a further discovery was made at Lindow Moss, just 250 m (820 ft) southwest of the Lindow Woman. On 1 August 1984, Andy Mould, who had been involved in the discovery of Lindow Woman, took what he thought was a piece of wood off the elevator of the peat-shredding machine. He threw the object at Eddie Slack, his workmate. When it hit the ground, peat fell off the object and revealed it to be a human foot. The police were called, and the foot was taken away for examination. At the same time Rachel Pugh, a trainee journalist for The Wilmslow World, was tipped off about the discovery. At the urging of her editor, she cycled out to the site of the discovery and persuaded the two men to show her where the foot had been excavated. Recognising the possible historical significance of the find, she told the diggers to stop work at once, and alerted Rick Turner, the Cheshire County Archaeologist, who subsequently succeeded in finding the rest of the body, which later became known as Lindow Man. Some skin had been exposed and had started to decay, so to prevent further deterioration of the body, it was re-covered with peat. The complete excavation of the block containing the remains was performed on 6 August. Until it could be dated, it was moved to the Macclesfield District General Hospital for storage. As the body of Malika Reyn-Bardt had still not been found, it was initially thought possible the body might be hers, until it was determined to be male, and radiocarbon dated.
Sources: en.wikipedia.org
== Other ventures == On "Double Cup", an episode of FXX's Major Lazer, he made a guest appearance as Double Cup, The Codeine Scientist. Riff Raff competed on a special for the MTV reality series The Challenge, premiering November 21, 2017, and titled Champs vs. Stars. On February 15, 2012, film director Harmony Korine contacted Riff Raff about appearing in an upcoming movie of his, which would turn out to be Spring Breakers. Once the details of the movie came out, there was speculation that the main character Alien was based on Riff Raff. However, according to James Franco, his character was based on the underground rap artist Dangeruss. He said "Of course Harmony and I looked at some of Riff Raff's videos as inspiration, but he was one of a number of people we looked at. I would say the biggest influence on the role was this local Florida rapper named Dangeruss. He's fairly unknown, but he was down there in the place, living the life, and he became the biggest model for me, and he's in the movie." There was much back and forth between both camps about the issue, including Riff Raff appearing in a cameo for One Life to Live playing a character called "Jamie Franko". In July 2013, Riff Raff announced he was suing the creators of Spring Breakers for $10 million for using his image without permission. However, a search for court documents by LA Weekly in September 2013 resulted in no findings. In 2017, Riff Raff partnered with Reef Dispensaries to develop and endorse two new strains of marijuana.
==== Liquid–liquid or solvent extraction ==== Liquid–liquid extraction or solvent extraction can be used to isolate YTXs from the sample medium. Methanol is normally the solvent of choice, but other solvents can also be used including acetone and chloroform. The drawback of using the solvent extraction method is the levels of analyte recovery can be poor, so any results obtained from the quantification processes may not be representative of the sample.
James Hibberd who commented for The Hollywood Reporter said that the trailer showed Homelander becoming more unstable after an apparent breakdown and also commenting over how the trailer also introduced a new formula that can turn anybody into a superhero for 24 hours, for which he complemented that Butcher might finally get the opportunity to be on the level of his nemesis and face him. Digital Spy's Shaun Wren deemed the trailer to be "packed with new heroes, gruesome scenes and a proper introduction to Jensen Ackles' original superhero Soldier Boy", and was excited to see the new developments that have taken during the time jump from the second to third season.
==== Other biosynthetic roles ==== Acetyl-CoA can be carboxylated in the cytosol by acetyl-CoA carboxylase, giving rise to malonyl-CoA, a substrate required for synthesis of flavonoids and related polyketides, for elongation of fatty acids to produce waxes, cuticle, and seed oils in members of the Brassica family, and for malonation of proteins and other phytochemicals. In plants, these include sesquiterpenes, brassinosteroids (hormones), and membrane sterols.
Counter-Strike (also known as Half-Life: Counter-Strike or Counter-Strike 1.6) is a 2000 tactical first-person shooter game developed by Valve Corporation and published by Sierra Studios. It is the first installment in the Counter-Strike series. The game pits two teams—the Counter-Terrorists and Terrorists—against each other in objective-based game modes. The most common objectives are bomb defusal and hostage rescue, each played on designated maps. Players begin with a knife and pistol, and they can purchase more advanced weapons and equipment with money earned through eliminating enemies or accomplishing goals. Once eliminated, players do not respawn until the end of the round. Minh Le and Jess Cliffe planned a game based on counter-terrorism in 1998 with development beginning the following year when the first few beta versions were released. Their initial version of the game started as a modification for Half-Life and gained significant popularity and interest, which attracted Valve. Valve went on to acquire the game's intellectual property and announced a partnership with Le and Cliffe. After finishing development, Counter-Strike was released by Valve for Microsoft Windows in November 2000. Several remakes and ports were released on Xbox, as well as OS X and Linux. Since its release, Counter-Strike received positive reviews from critics who praised the gameplay and its emphasis on teamwork and strategy. It has been called one of the most influential first-person shooters and noted for its realistic and tactical approach to counter-terrorism.
Sources: en.wikipedia.org
TB-500 is a synthetic heptapeptide corresponding to a fragment of thymosin beta-4. It is used in laboratory research and is not an approved drug.
No. Thymosin beta-4 is a 43-amino-acid protein, while TB-500 represents only a short N-terminal segment. The two should not be treated as interchangeable in experimental design.
It is often called a thymosin beta-4 fragment, Tβ4 fragment, or Ac-LKKTETQ. The name TB-500 is mainly a commercial or catalog label rather than a formal chemical name.
Dry lyophilized powder is usually kept frozen, desiccated, and out of direct light. Sealed vials are not opened until needed, because moisture uptake can degrade short peptides. Longer archival storage is often done at lower temperatures than routine working stock.